| Patents for C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies (149,320) |
|---|
| 02/03/2011 | WO2011013470A1 Autoantibody production inhibitor |
| 02/03/2011 | WO2011012609A2 Ligands that bind tgf-beta receptor rii |
| 02/03/2011 | WO2011012309A1 Muc1 antibodies |
| 02/03/2011 | WO2011012297A1 Enzymatic antibody processing |
| 02/03/2011 | WO2011012254A1 Pichia pastoris as a host for the production of the ribosome-inactivating protein (rip) saporin and saporin fusion chimaeras |
| 02/03/2011 | WO2011012098A1 Method for detecting and identifying a variant c. difficile strain in a sample |
| 02/03/2011 | WO2011011879A1 H. pylori lipopolysaccharide outer core epitope |
| 02/03/2011 | WO2010126590A8 Ptp1b inhibitors |
| 02/03/2011 | WO2010115868A3 Therapeutic agents for the treatment of diseases associated with undesired cell proliferation |
| 02/03/2011 | WO2010054377A9 Fully human antibodies against n-cadherin |
| 02/03/2011 | WO2010028796A8 Trispecific hexavalent antibodies |
| 02/03/2011 | WO2007035872A3 Tdf-related compounds and analogs thereof |
| 02/03/2011 | US20110030098 Glycosyltransferases, Polynucleotides Encoding These And Methods Of Use |
| 02/03/2011 | US20110030096 AXMI-192 Family of Pesticidal Genes and Methods for Their Use |
| 02/03/2011 | US20110030073 Therapeutic targets and medicaments involving p230/golgin-245 |
| 02/03/2011 | US20110028698 Modified Chimeric Polypeptides with Improved Pharmacokinetic Properties |
| 02/03/2011 | US20110028697 Prophylactic/therapeutic agent for infectious disease |
| 02/03/2011 | US20110028696 Monoclonal antibodies against prostate specific membrane antigen (psma) lacking in fucosyl residues |
| 02/03/2011 | US20110028695 Method for obtaining polypeptide constructs comprising two or more single domain antibodies |
| 02/03/2011 | US20110028694 Methods to express recombinant proteins from lentiviral vectors |
| 02/03/2011 | US20110028686 Protein binding miniature proteins |
| 02/03/2011 | US20110028399 Citrullinated cytokines |
| 02/03/2011 | US20110028387 METHODS OF SCREENING OF PP1-INTERACTING POLYPEPTIDES OR PROTEINS, PEPTIDES INHIBITING PP1c BINDING TO Bcl-2 PROTEINS, BCL-XL AND BCL-W, AND USES THEREOF |
| 02/03/2011 | US20110028348 Binding polypeptides with optimized scaffolds |
| 02/03/2011 | US20110028344 Biomarkers for endometrial disease |
| 02/03/2011 | US20110028335 Ligands For The GLP-1 Receptor And Methods For Discovery Thereof |
| 02/03/2011 | US20110027909 Chimera Compositions and Methods of Use |
| 02/03/2011 | US20110027807 Protein specific to pancreatic beta cells in islets of langerhans and applications thereof |
| 02/03/2011 | US20110027805 Acpl-related assays |
| 02/03/2011 | US20110027800 Derivatives of 1,2-dihydro-7-hydroxyquinolines Containing Fused Rings |
| 02/03/2011 | US20110027797 Method for the Diagnosis of Higher- and Lower-Grade Astrocytoma Using Biomarkers and Diagnostic Kit Thereof |
| 02/03/2011 | US20110027303 Partial peptide of survivin presented on mhc class ii molecule and use therof |
| 02/03/2011 | US20110027299 Melanoma antigens and their use in diagnostic and therapeutic methods |
| 02/03/2011 | US20110027297 Methods Involving MS4A12 and Agents Targeting MS4A12 for Therapy, Diagnosis and Testing |
| 02/03/2011 | US20110027294 Anti-Respiratory Syncytial Virus Antibodies, Antigens and Uses Thereof |
| 02/03/2011 | US20110027293 Methods and compositions for the inhibition of viral infection by targeting intracellular trafficking |
| 02/03/2011 | US20110027290 Anti-il-17 antibodies |
| 02/03/2011 | US20110027287 Antigen binding proteins to proprotein convertase subtilisin kexin type 9 (pcsk9) |
| 02/03/2011 | US20110027286 High Affinity Human Antibodies to Human Angiopoietin-2 |
| 02/03/2011 | US20110027285 Methods and agents modulating upa/upar activity |
| 02/03/2011 | US20110027284 Nogo-a binding molecules and pharmaceutical use thereof |
| 02/03/2011 | US20110027282 Interferon antagonists, antibodies thereto and associated methods of use |
| 02/03/2011 | US20110027281 Single domain antibodies directed against tumor necrosis factor-alpha and uses therefor |
| 02/03/2011 | US20110027280 Methods For Inducing Autolysis In Infectious Bacteria |
| 02/03/2011 | US20110027279 Recombinant antibodies specific for beta-amyloid ends, dna encoding and methods of use thereof |
| 02/03/2011 | US20110027278 Regulatory t cell mediator proteins and uses thereof |
| 02/03/2011 | US20110027277 Predictive marker for topoisomerase i inhibitors |
| 02/03/2011 | US20110027276 Optimized CD40 Antibodies and Methods of Using the Same |
| 02/03/2011 | US20110027274 Antiproliferative compounds, conjugates thereof, methods therefor, and uses thereof |
| 02/03/2011 | US20110027272 Stabilized liquid anti-rsv antibody formulations |
| 02/03/2011 | US20110027271 Antibody composition exhibiting cellular cytotoxicty due to glycosylation |
| 02/03/2011 | US20110027270 Monoclonal antibodies against influenza virus generated by cyclical administration and uses thereof |
| 02/03/2011 | US20110027269 14-3-3 Antagonists for the Prevention and Treatment of Arthritis |
| 02/03/2011 | US20110027268 Anti-mesothelin antibodies and uses thereof |
| 02/03/2011 | US20110027266 Humanized anti-CXCR5 antibodies, derivatives thereof and their use |
| 02/03/2011 | US20110027261 Anti-hepcidin antibodies and uses thereof |
| 02/03/2011 | US20110027185 Methods of Screening for Anti-Angiogenic Compounds |
| 02/03/2011 | US20110027182 Substance for obtaining highly effective tumor medications as well as a process |
| 02/03/2011 | US20110027180 Detection and treatment of prostate cancer |
| 02/03/2011 | CA2769518A1 Dual variable domain immunoglobulins and uses thereof |
| 02/03/2011 | CA2769473A1 Fully human antibodies to btla |
| 02/03/2011 | CA2769334A1 High affinity human antibodies to human angiopoietin-2 |
| 02/03/2011 | CA2769308A1 Inhibition of tumor metastasis using bv8- or g-csf-antagonists |
| 02/03/2011 | CA2768981A1 Ligands that bind tgf-beta receptor rii |
| 02/03/2011 | CA2768888A1 Muc1 antibodies |
| 02/03/2011 | CA2768528A1 Method for detecting and identifying a variant c. difficile strain in a sample |
| 02/03/2011 | CA2766839A1 Enzymatic antibody processing |
| 02/03/2011 | CA2762366A1 H. pylori lipopolysaccharide outer core epitope |
| 02/02/2011 | EP2280282A1 Methods of detecting Lp-PLA2 activity |
| 02/02/2011 | EP2280082A2 Identification of surface-associated antigenes used for the diagnosis and therapy of tumours |
| 02/02/2011 | EP2280072A2 Group B streptococcus antigens |
| 02/02/2011 | EP2280067A2 Novel genes encoding novel proteolytic enzymes |
| 02/02/2011 | EP2280063A1 Pichia pastoris as a host for the production of the ribosome-inactivating protein (RIP) saporin and saporin fusion chimaeras |
| 02/02/2011 | EP2280030A2 Nucleic acids and corresponding proteins useful in the detection and treatment of various cancers |
| 02/02/2011 | EP2279755A2 Remodelling and glycoconjugation of Fibroblast Growth Factor (FGF) |
| 02/02/2011 | EP2279754A2 Remodelling and glycoconjugation of human growth hormone (hGH) |
| 02/02/2011 | EP2279753A2 Remodeling and glycoconjugation of peptides |
| 02/02/2011 | EP2279749A1 Binding molecules for treatment and detection of cancer |
| 02/02/2011 | EP2279413A2 Methods, antibodies and kits for detecting cerebrospinal fluid in a sample |
| 02/02/2011 | EP2279412A2 Novel compositions and methods for the treatment of immune related diseases |
| 02/02/2011 | EP2279209A2 Amino acid sequences directed against integrins and uses thereof |
| 02/02/2011 | EP2279208A1 Single domain antibodies that bind il-13 |
| 02/02/2011 | EP2279207A2 Humanized antibodies against human interferon-alpha |
| 02/02/2011 | EP2279206A1 Method of preventing the development of rheumatoid arthritis in subjects with undifferentiated arthritis |
| 02/02/2011 | EP2279203A2 Prion epitopes and methods of use thereof |
| 02/02/2011 | EP2279004A2 Use of biomarkers for assessing treatment of gastrointestinal inflammatory disorders with beta7integrin antagonists |
| 02/02/2011 | EP2279003A2 An anti-cd137 antibody as an agent in the treatment of inflammatory conditions |
| 02/02/2011 | EP2279002A2 Anti-nucleic acid antibody inducing cell death of cancer cells and composition for preventing or treating cancers comprising the same |
| 02/02/2011 | EP2279001A1 Inhibitors of gm-csf and il-17 for therapy |
| 02/02/2011 | EP2279000A1 Method for the prevention and treatment of cancer by inhibition of gpvi |
| 02/02/2011 | EP2278990A2 Ezrin, serpin b5, peroxiredoxin-2 and heat shock protein beta-1 as autoantigens for treating or detecting streptococcal diseases |
| 02/02/2011 | EP1805222B1 Antibodies directed to the mammalian eag1 ion channel protein |
| 02/02/2011 | EP1618126B1 Sars-related proteins |
| 02/02/2011 | EP1603949B9 Antibodies against human il-21 receptor and uses therefor |
| 02/02/2011 | EP1556083B1 Methods for treating post-surgical pain by admisnistering an antibody against nerve growth factor and compositions containing the same |
| 02/02/2011 | EP1447448B1 Novel n-acetylglucosamine transferase, nucleic acid encoding the same, antibody against the same and use thereof for diagnosing cancer or tumor |
| 02/02/2011 | EP1301532B1 Plant cyclin-dependent kinase inhibitors |
| 02/02/2011 | CN1970573B Neutrality monoclonal antibody 3E1 for resisting ricin, its preparation method and uses |
| 02/02/2011 | CN101965403A Composition for neutralizing botulinus toxin type-a, and human anti-botulinus toxin type-a antibody |
| 02/02/2011 | CN101965397A Transferases and Oxidoreductases, Nucleic Acids Encoding them and methods for making and using them |